In contrast to the notion of GSK3β as a tumor suppressor, a growing number of studies over the past 15 years by our group and many others have instead shown that aberrant expression and activity of GSK3β facilitates the progression of various cancer types (reviewed in [21,22,23]). This evidence concerns the gene GSK3B and cancer.